Search

everythinglearnresearchcommunity

for

Search:↓

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

DHEA is the main sex steroid in cerebrospinal fluid, and testosterone in the fluid comes from the blood.

Effective treatments for hair loss include minoxidil, 5α-reductase inhibitors, and personalized combination therapies.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

A new method was developed to accurately measure enzyme activity related to prostate health.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Hair loss is mainly caused by a testosterone byproduct, and hair restoration surgery uses hair from the back and sides of the scalp.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Hirsutism in women can be a cosmetic issue or a sign of hormonal imbalance, treatable with hormonal and cosmetic methods.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Using hair grafts from outside the safe zone requires careful placement to improve their survival and effectiveness.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

High levels of testosterone and dihydrotestosterone inhibit hair cell growth, while high levels of estradiol promote it.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.